Immunological activation of oncogenic viruses: interrelationship of immunostimulation and immunosuppression.
D000818:Animals; D000917:Antibody Formation; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006084:Graft Rejection; D006087:Graft vs Host Reaction; D006801:Humans; D007065:Idoxuridine / Q000494:pharmacology; D007108:Immune Tolerance; D007372:Interferons / Q000627:therapeutic use; D009052:Leukemia Virus, Murine / Q000187:drug effects / Q000276:immunology; D007942:Leukemia, Experimental / Q000209:etiology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology; D008223:Lymphoma / Q000209:etiology / Q000517:prevention & control; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008815:Mice, Inbred Strains; D008934:Mitogens / Q000494:pharmacology; D009369:Neoplasms / Q000276:immunology*; D009374:Neoplasms, Experimental; D009858:Oncogenic Viruses / Q000276:immunology*; D012190:Retroviridae / Q000302:isolation & purification; D016038:Skin Transplantation; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D008934:Mitogens; D007372:Interferons; D007065:Idoxuridine